Perceptive Advisors LLC Voyager Therapeutics, Inc. Transaction History

Perceptive Advisors LLC

  • $3.83 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019
SELL
$16.31 - $28.29 $596,505 - $1.03 Million
-36,573 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$19.18 - $27.88 $701,470 - $1.02 Million
36,573 New
36,573 $996,000
Q4 2017

Feb 14, 2018
SELL
$12.26 - $25.88 $424,245 - $895,551
-34,604 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$8.37 - $20.59 $289,635 - $712,496
34,604
34,604 $712,000

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $206M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email